Media Partners

 

全体基調講演

Tri-Conferenceは、疾病の症状緩和、医療アクセスの改善、大きな変化をもたらす治療法の発見などで重要な役割を担う分子医学、診断、創薬、医薬品開発などの分野の新たな技術や研究の可能性を見極めるためのプラットフォームとなっており、今後もこの役割を担い続けていきます。およそ1,000人を超える方々が集まる全体基調講演は、各カンファレンスプログラムの出席者が一堂に会する唯一のセッションであり、会期中毎日行われます。

3月11日(月) 5:00 - 6:00PM

5:00 Welcome Remarks
Cindy Crowninshield, RDN, LDN, HHC, Executive Event Director, Cambridge Healthtech Institute

Rheonix5:05 Keynote Introduction
Peter Trabold, PhD, MBA, Director, Clinical Applications, Rheonix

5:15 生体試料の寄付: 試料を提供した家族と、その研究により生体医学を前進させた遺伝子診断研究所の軌跡
Sarah shares the now world-famous story of how she anonymously donated her infant son’s post-mortem tissue for biomedical research to some of the most prestigious scientific facilities in the country, including the University of Pennsylvania. Years later, she tracked down each donation. She met with researchers and scientists who received the donations to learn how they are being studied in cutting-edge research for medical discoveries. One of these research scientists who received her son’s retinas is Dr. Arupa Ganguly. Dr. Ganguly directs the genetic diagnostic lab at the University of Pennsylvania and studies retinoblastoma, a childhood-onset cancer caused by mutations in tumor suppression gene. They will share their experience and perspective on biospecimen donation.

Speakers:
Gray_SarahSarah Gray, Author, A Life Everlasting: The Extraordinary Story of One Boy’s Gift to Medical Science 
Ganguly_ArupaArupa Ganguly, PhD, Professor of Genetics, Perelman School of Medicine, University of Pennsylvania

 

 

6:00 Grand Opening Reception in the Exhibit Hall with Poster Viewing and Book Signing*

*Book Signing with Sarah Gray, Author, A Life Everlasting: The Extraordinary Story of One Boy’s Gift to Medical Science
Book will be available for purchase onsite

3月12日(火) 8:00 - 9:15AM

8:00 Welcome Remarks
Cindy Crowninshield, RDN, LDN, HHC, Executive Event Director, Cambridge Healthtech Institute

Lucidworks8:05 Keynote Introduction
Speaker to be Announced, Lucidworks

8:15 個別化医療を実現するためのデータサイエンス
Big data and machine learning have the potential to improve health, detecting disease at an earlier stage and personalizing interventions. The key ingredient, some say, is applying algorithms to population-wide datasets. But the question remains: is it enough to train smarter algorithms with broader datasets? What other approaches, diagnostics tools, and technologies do we need to accurately assess a patient’s unique needs and build a personalized intervention? A panel of experts across diagnostics, informatics, and therapeutics from government, academia, integrated health centers, data science, and biopharma will lead a highly interactive exploration of these issues and predict what it will take to realize the role of data science enabling personalized medicine.

Moderator: Marty Tenenbaum, PhD, Founder and Chairman, Cancer Commons; Prominent AI Researcher; Cancer Survivor


Panelists:

Tanya CashoraliTanya Cashorali, CEO, Founder, TCB Analytics


Dalton_BillWilliam (Bill) S. Dalton, PhD, MD, Founder and Executive Chair, M2Gen


Gottfried_SaraSara Gottfried, MD, Chief Medical Officer, Metagenics


Kaushik_GauravGaurav Kaushik, Associate Director, Data Products & Strategy, Foundation Medicine, Inc.


David SmoleyDavid Smoley, CIO, AstraZeneca


Additional Speakers to be Announced

 

9:15 Refreshment Break in the Exhibit Hall with Poster Viewing

3月13日(水) 8:00 - 10:00AM

8:00 Welcome Remarks
Cindy Crowninshield, RDN, LDN, HHC, Executive Event Director, Cambridge Healthtech Institute

8:15 Diagnostics World Early Innovator Award Program
Benjamin Ross, Senior Editorial Assistant, Bio-IT World

8:30 基調パネルディスカッション:新たな技術と業界の展望
A popular session at Tri-Conference! This panel session will feature a series of short podium presentations on emerging and hot technologies in molecular medicine. Each speaker will have 7 minutes to present. After all speakers have presented, there will be a moderated Q&A with attendees. The presentations are not meant to be a corporate or specific product pitch. Each speaker will focus on a technology and solution framed around a motivational clinical problem and how their particular company/organization is solving it.

Moderators:

Kristin Ciriello Pothier, Global Head of Life Sciences Strategy, Parthenon-EY; Author, Personalizing Precision Medicine


Scott Palmer, Vice President and Head of Precision Medicine, Parthenon-EY


Panelists:

Arianpour_ArdyArdy Arianpour, CEO & Co-Founder, Seqster


Packard_NormanNorman Packard, CEO, Daptics


Ianelli_ChrisChris Ianelli, PhD, MD, Founder & CEO, iSpecimen


Speaker to be Announced, Ximedica

Krueger_JosephJoseph Krueger, CSO, Flagship Biosciences


Florian Bell, Senior Member, Technical Staff-System Integration, Qorvo Biotechnologies, LLC

Speaker to be Announced, Benchling

Speaker to be Announced, ANGLE plc

Additional Speakers to be Announced

 

10:00 Refreshment Break and Poster Competition Winner Announced in the Exhibit Hall

* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。

Choose your language
Traditional Chinese
Simplified Chinese
Korean
English


更新通知サービス
更新履歴
2019/02/13
イベント情報更新
2019/02/01
アジェンダ・スポンサー更新
2019/01/09
スポンサー更新




メール配信サービス